Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | LQDA | XENE | ||
| Company | Apellis Pharmaceuticals Inc | Liquidia Corp | Xenon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.05 | 61.74 | 54.16 | ||
| High | 41.07 | 62.29 | 55.35 | ||
| Low | 41.03 | 60.79 | 53.86 | ||
| Latest | 41.03 | 60.98 | 54.17 | ||
| Change | -0.03 | -0.99 | +0.05 | ||
| % Change | -0.07% | -1.60% | +0.09% | ||
| Volume | 68,611,400 | 974,100 | 969,800 | ||
| 20-Day Average Volume | 7,541,190 | 1,647,965 | 990,530 | ||
| Previous Close | 41.06 | 61.97 | 54.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.97 | 49.05 | 55.53 | ||
| 20-Day Raw Stochastic | 67.65% | 94.86% | 21.98% | ||
| 20-Day Relative Strength | 81.66 | 76.16 | 47.20 | ||
| Weighted Alpha | +25.64 | +227.27 | +59.22 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 05/06/26 | +7.11% since 05/15/26 | -0.40% since 05/15/26 | ||
| Low | 40.98 on 05/07/26 | 56.02 on 05/18/26 | 52.85 on 05/19/26 | ||
| High | 41.08 on 05/12/26 | 62.30 on 05/21/26 | 55.80 on 05/20/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 04/13/26 | +64.54% since 04/22/26 | -4.38% since 04/22/26 | ||
| Low | 40.78 on 04/14/26 | 36.02 on 04/24/26 | 52.85 on 05/19/26 | ||
| High | 41.14 on 05/06/26 | 62.30 on 05/21/26 | 58.85 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +89.08% since 02/13/26 | +81.54% since 02/20/26 | +28.27% since 02/20/26 | ||
| Low | 16.83 on 03/30/26 | 29.12 on 02/26/26 | 41.05 on 03/06/26 | ||
| High | 41.14 on 05/06/26 | 62.30 on 05/21/26 | 63.95 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +107.12% since 11/13/25 | +109.48% since 11/21/25 | +31.61% since 11/21/25 | ||
| Low | 16.83 on 03/30/26 | 28.00 on 11/24/25 | 39.29 on 01/20/26 | ||
| High | 41.14 on 05/06/26 | 62.30 on 05/21/26 | 63.95 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,252,701 | 5,422,830 | 5,236,397 | ||
| Shares Outstanding, K | 128,021 | 88,928 | 96,666 | ||
| Annual Sales | 1,003,780,000 | 158,320,000 | 7,500,000 | ||
| Annual Net Income | 22,390,000 | -68,920,000 | -345,910,000 | ||
| Last Quarter Sales | 268,300,000 | 132,870,000 | 0 | ||
| Last Quarter Net Income | 18,660,000 | 52,860,000 | -102,300,000 | ||
| 60-Month Beta | -0.24 | 0.41 | 0.65 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | 0.52 on 05/11/26 | -1.17 on 05/07/26 | ||
| Earnings Date | 07/30/26 | 08/11/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.25 | 442.64 | 0.00 | ||